Study of Lactobacillus in Adjuvant Treatment of RVVC

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Recurrent Vulvovaginal Candidiasis
Interventions
DRUG

clotrimazole vaginal tablets

Intensive treatment: clotrimazole vaginal tablets 500mg, every 72 hours, three consecutive times Consolidation treatment: clotrimazole vaginal tablets 500mg, once a week, 6 months

DRUG

Clotrimazole vaginal tablets+ Lactobacillus

Intensive treatment: clotrimazole vaginal tablets 500mg, every 72 hours, three consecutive times Consolidation treatment: clotrimazole vaginal tablets 500mg, once a week, 6 months Human Reproductive Tract Active Lactobacillus,4g,qd ,3months

Trial Locations (1)

518036

Dept Obstetrics and Gynecology, Shenzhen

All Listed Sponsors
lead

Peking University Shenzhen Hospital

OTHER

NCT04699240 - Study of Lactobacillus in Adjuvant Treatment of RVVC | Biotech Hunter | Biotech Hunter